Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 4.29 EUR -6.94% Market Closed
Market Cap: 120.1m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyloris Pharmaceuticals SA
Research & Development Peer Comparison

Comparables:
UCB
TUB

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
Research & Development
-€14.4m
CAGR 3-Years
-70%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
Research & Development
-€1.6B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hyloris Pharmaceuticals SA's Research & Development?
Research & Development
-14.4m EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's Research & Development amounts to -14.4m EUR.

What is Hyloris Pharmaceuticals SA's Research & Development growth rate?
Research & Development CAGR 5Y
-24%

Over the last year, the Research & Development growth was -40%. The average annual Research & Development growth rates for Hyloris Pharmaceuticals SA have been -70% over the past three years , -24% over the past five years .

Back to Top